Use of CPAP to reduce arterial stiffness in moderate-to-severe obstructive sleep apnoea, without excessive daytime sleepiness (STIFFSLEEP): an observational cohort study protocol

Maria Alexandra Mineiro, Pedro Marques da Silva, Marta Alves, Daniel Virella, Maria João Marques Gomes, João Cardoso, Maria Alexandra Mineiro, Pedro Marques da Silva, Marta Alves, Daniel Virella, Maria João Marques Gomes, João Cardoso

Abstract

Introduction: Sleepiness is a cardinal symptom in obstructive sleep apnoea (OSA) but most patients have unspecific symptoms. Arterial stiffness, evaluated by pulse wave velocity (PWV), is related to atherosclerosis and cardiovascular (CV) risk. Arterial stiffness was reported to be higher in patients with OSA, improving after treatment with continuous positive airway pressure (CPAP). This study aims to assess whether the same effect occurs in patients with OSA and without sleepiness.

Methods and analysis: This observational study assesses the CV effect of CPAP therapy on a cohort of patients with moderate-to-severe OSA; the effect on the subcohorts of sleepy and non-sleepy patients will be compared. A systematic and consecutive sample of patients advised CPAP therapy will be recruited from a single outpatient sleep clinic (Centro Hospitalar de Lisboa Central-CHLC, Portugal). Eligible patients are male, younger than 65 years, with confirmed moderate-to-severe OSA and apnoea-hypopnea index (AHI) above 15/hour. Other sleep disorders, diabetes or any CV disease other than hypertension are exclusion criteria. Clinical evaluation at baseline includes Epworth Sleepiness Scale (ESS), and sleepiness is defined as ESS above 10. OSA will be confirmed by polygraphic study (cardiorespiratory, level 3). Participants are advised to undertake an assessment of carotid-femoral PWV (cf-PWV) and 24 hours evaluation of ambulatory blood pressure monitoring (ABPM), at baseline and after 4 months of CPAP therapy. Compliance and effectiveness of CPAP will be assessed. The main outcome is the variation of cf-PWV over time.

Ethics and dissemination: This protocol was approved by the Ethics Committees of CHLC (reference number 84/2012) and NOVA Medical School (number36/2014/CEFCM), Lisbon. Informed, written consent will be obtained. Its results will be presented at conferences and published in peer-reviewed journals.

Trial registration number: NCT02273089; Pre-results.

Keywords: Arterial stiffness; Obstructive sleep apnea; Pulse wave velocity; Sleepiness.

Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/

Figures

Figure 1
Figure 1
Study design. ABPM, ambulatory blood pressure monitoring; CF-PWV, carotid-femoral pulse wave velocity; CPAP, continuous positive airway pressure; ESS, Epworth Sleepiness Scale; OSA, obstructive sleep apnoea.

References

    1. Young T, Finn L, Peppard PE et al. . Sleep disordered breathing and mortality: eighteen-year follow-up of the Wisconsin Sleep Cohort. Sleep 2008;31:1071–8.
    1. Marin JM, Carrizo SJ, Vicente E et al. . Long-term cardiovascular outcomes in men with obstructive sleep apnoea-hypopnoea with or without treatment with continuous positive airway pressure: an observational study. Lancet 2005;365:1046–53. 10.1016/S0140-6736(05)71141-7
    1. Peker Y, Hedner J, Norum J et al. . Increased incidence of cardiovascular disease in middle-aged men with obstructive sleep apnea. A 7-year follow-up. Am J Respir Crit Care Med 2002;166:159–65. 10.1164/rccm.2105124
    1. Epstein LJ, Kristo D, Strollo PJ et al. . Clinical guideline for the evaluation, management and long-term care of obstructive sleep apnea in adults. Adult Obstructive Sleep Apnea Task Force of the American Academy of Sleep Medicine. J Clin Sleep Med 2009;5:263–76.
    1. McNicholas WT. Diagnosis of obstructive sleep apnea in adults. Proc Am Thorac Soc 2008;5:154–60. 10.1513/pats.200708-118MG
    1. Johns MW. A new method for measuring daytime sleepiness: the Epworth Sleepiness Scale. Sleep 1991;14:540–5.
    1. Lloberes P, Durán-Cantolla J, Martínez-García MA et al. , SEPAR Guidelines. Diagnosis and treatment of sleep apnea-hypopnea syndrome. Arch Bronconeumol 2011;47:143–56. 10.1016/j.arbres.2011.01.001
    1. Oksenberg A, Arons E, Nasser K et al. . Severe obstructive sleep apnea: sleepy versus non sleepy patients. Laryngoscope 2010;120:643–8. 10.1002/lary.20758
    1. Kapur VK, Baldwin CM, Resnick HE et al. . Sleepiness in patients with moderate to severe sleep-disordered breathing. Sleep 2005;28:472–7.
    1. Bratton DJ, Stradling JR, Barbé F et al. . Effect of CPAP on blood pressure in patients with minimally symptomatic obstructive sleep apnoea: a meta-analysis using individual patient data from four randomised controlled trials. Thorax 2014;69:1128–35. 10.1136/thoraxjnl-2013-204993
    1. Mancia G, Fagard R, Narkiewicz K et al. . 2013 Guidelines for the Management of Arterial Hypertension: the Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens 2013;31:1281–357. 10.1097/
    1. Vlachopoulos C, Xaplanteris P, Aboyans V et al. . The role of vascular biomarkers for primary and secondary prevention. A position paper from the European Society of Cardiology Working Group on peripheral circulation: endorsed by the Association for Research into Arterial Structure and Physiology (ARTERY) Society . Atherosclerosis 2015;241:507–32. 10.1016/j.atherosclerosis.2015.05.007
    1. Vlachopoulos C, Aznaouridis K, Stefanadis C. Prediction of cardiovascular events and all-cause mortality with arterial stiffness. A systematic review and meta-analysis. J Am Coll Cardiol 2010;55:1318–27. 10.1016/j.jacc.2009.10.061
    1. Doonan RJ, Scheffler P, Lalli M et al. . Increased arterial stiffness in obstructive sleep apnoea: a systematic review. Hypertens Res 2011;34:23–32. 10.1038/hr.2010.200
    1. Drager LF, Bortolotto LA, Lorenzi MC et al. . Early signs of atherosclerosis in obstructive sleep apnea. Am J Respir Crit Care Med 2005;172:613–18. 10.1164/rccm.200503-340OC
    1. VlachantoniI IT, Dikaiakou E, Antonopoulos CN et al. . Effects of continuous positive airway pressure (CPAP) treatment for obstructive sleep apnea in arterial stiffness: a meta-analysis. Sleep Med Rev 2013;17:19–28. 10.1016/j.smrv.2012.01.002
    1. Wons AM, Kohler M. Established vascular effects of continuous positive airway pressure therapy in patients with obstructive sleep apnoea—an update. J Thorac Dis 2015;7:912–19. 10.3978/j.issn.2072-1439.2015.03.06
    1. Mota PC, Drummond M, Winck JC et al. . APAP impact on metabolic syndrome in obstructive sleep apnea patients. Sleep Breath 2011;15:665–72. 10.1007/s11325-010-0417-5
    1. Alberti KG, Eckel RH, Grundy SM et al. . Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation 2009;120:1640–5. 10.1161/CIRCULATIONAHA.109.192644
    1. Iber CI, Ancoli-Israel S, Chesson L et al. . for the American Academy of Sleep Medicine. Rules, terminology and technical specifications: the AASM Manual for Scoring of Sleep and Associated Events 2007.
    1. Van Bortel LM, Laurent S, Boutouyrie P et al. . Expert consensus document on the measurement of aortic stiffness in daily practice using carotid-femoral pulse wave velocity. J Hypertens 2012;30:445–8. 10.1097/HJH.0b013e32834fa8b0
    1. Masa JF, Jiménez A, Duran J et al. . Alternative methods of titrating continuous positive airway pressure. A large multicenter study. Am J Respir Crit Care Med 2004;170:1218–24. 10.1164/rccm.200312-1787OC
    1. Schwab RJ, Badr SM, Epstein LJ et al. . An official American Thoracic Society statement: continuous positive airway pressure adherence tracking systems. The optimal monitoring strategies and outcome measures in adults. Am J Respir Crit Care Med 2013;188:613–20. 10.1164/rccm.201307-1282ST

Source: PubMed

赞助者和合作者

医疗条件

药物干预

3
订阅